» Articles » PMID: 25350650

The 30-day Versus In-hospital and 90-day Mortality After Esophagectomy As Indicators for Quality of Care

Overview
Journal Ann Surg
Specialty General Surgery
Date 2014 Oct 29
PMID 25350650
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe causes of death in the first year after esophagectomy and determine the time frame that should be used for measurement of quality of surgery. A case-mix adjustment model was developed for the comparison between hospitals.

Background: The time period in which postoperative mortality should be measured as a performance indicator is debated.

Methods: Cause of death was identified for patients in a tertiary referral hospital who died within 1 year after surgery and classified as surgery related or not surgery related. Sensitivity and specificity for detecting deaths related to surgery were calculated for different periods of follow-up. Case-mix adjustment models for 30-day mortality (30DM), in-hospital mortality, and 90-day mortality (90DM) were developed.

Results: In total, 1282 patients underwent esophagectomy. 30DM was 2.9%, the in-hospital mortality rate was 5.1% and 90DM was 7%. Beyond 30 days, a substantial number of deaths were related to the operation, especially due to anastomotic leakage. Postdischarge nononcological mortality was most frequently caused by sudden death. One in 5 patients died because of recurrent disease, being the most important threat in the first year after surgery. The 30DM had a sensitivity for detecting surgery-related deaths of 33% and a specificity of 100%. The 90DM had a sensitivity of 74% and a specificity of 96%.

Conclusions: A period of postoperative follow-up longer than 30 days needs to be considered when comparing surgical performance between institutes. In the case-mix adjustment model for 90DM, no other variables have to be taken into account compared to those involved in 30DM.

Citing Articles

Estimation of the postoperative fatality window in colorectal cancer surgery.

Rutegard M, Matthiessen P, Rutegard J, Haapamaki M, Svensson J BJS Open. 2025; 9(1.

PMID: 39851201 PMC: 11758370. DOI: 10.1093/bjsopen/zrae153.


Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.

Damen P, van Rossum P, Chen Y, Abana C, Liao Z, Hobbs B Int J Part Ther. 2024; 11:100012.

PMID: 38757082 PMC: 11095098. DOI: 10.1016/j.ijpt.2024.100012.


Short-term outcomes of robot-assisted versus conventional minimally invasive esophagectomy for esophageal cancer: a systematic review and meta-analysis of 18,187 patients.

Perry R, Barbosa J, Perry I, Barbosa J J Robot Surg. 2024; 18(1):125.

PMID: 38492067 PMC: 10944433. DOI: 10.1007/s11701-024-01880-3.


Quality Performance Indicators for the Surgical Management of Oesophageal Cancer: A Systematic Literature Review.

Kulasegaran S, Wang Y, Woodhouse B, MacCormick A, Srinivasa S, Koea J World J Surg. 2023; 47(12):3262-3269.

PMID: 37865917 PMC: 10694097. DOI: 10.1007/s00268-023-07216-w.


Applications of endoscopic vacuum therapy in the upper gastrointestinal tract.

Kouladouros K World J Gastrointest Endosc. 2023; 15(6):420-433.

PMID: 37397978 PMC: 10308278. DOI: 10.4253/wjge.v15.i6.420.